You might get one of these:
Underlying causes of extrinsic hemolytic anemia include:
Warm Autoimmune Hemolytic Anemia
Other specified abnormal immunological findings in serum The 2022 edition of ICD-10-CM R76. 8 became effective on October 1, 2021. This is the American ICD-10-CM version of R76.
A: ICD-10-CM code category D59. - (acquired hemolytic anemia) includes codes for hemolytic anemia from acquired conditions that result in the premature destruction of red blood cells, as opposed to hereditary disorders causing anemia.
Coombs-negative hemolytic anemia is characterized by laboratory evidence of hemolysis plus a negative Coombs test. Various viral infections have been associated with Coombs-negative hemolytic anemia including hepatitis A virus, hepatitis E virus, cytomegalovirus, and influenza [14].
ICD-10 code D59. 1 for Other autoimmune hemolytic anemias is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
Differential Diagnosis Spherocytosis, reticulocytosis, and positive antiglobulin (Coombs) tests are characteristic laboratory features of AIHA. AIHA is distinguished from hereditary spherocytosis by lack of a family history and positive antiglobulin tests.
Hemolytic anemia is a blood condition that occurs when your red blood cells are destroyed faster than they can be replaced.
An abnormal (positive) direct Coombs test means you have antibodies that act against your red blood cells. This may be due to: Autoimmune hemolytic anemia. Chronic lymphocytic leukemia or similar disorder. Blood disease in newborns called erythroblastosis fetalis (also called hemolytic disease of the newborn)
The Coombs test detects agglutination (clumping) of red blood cells. If no clump is detected, the test result is negative. This means that there were no antibodies detected or that the amount of antibodies present is likely insignificant. Agglutination of the red blood cells during the test indicates a positive result.
The principal reasons for DAT-negative AIHA are: (a) RBC-bound IgG being below the threshold of detection by standard methods; (b) low affinity of IgG; and (c) RBC-bound IgA or rarely IgM [4].
Warm autoimmune hemolytic anemia (WAHA) is an autoimmune disorder characterized by the premature destruction of healthy red blood cells (hemolysis). Autoimmune diseases occur when one's own immune system attacks healthy tissue.
Medications that work for warm autoimmune hemolytic anemia include corticosteroids or immunosuppressants. If that approach doesn't work, then you may need a splenectomy. Blood transfusions are considered in the situation of severe anemia as supportive care while the disease is being treated.
Other megaloblastic anemias, not elsewhere classified D53. 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D53. 1 became effective on October 1, 2021.
Autoimmune hemolytic anemia happens when your immune system attacks your red blood cells. Symptoms may be mild or severe and can be treated using a number of different methods. While AIHA is highly treatable, it can be serious — and even fatal — if left unaddressed.
Hemolytic anemia can be inherited or acquired: Inherited hemolytic anemia happens when parents pass the gene for the condition on to their children. Acquired hemolytic anemia is not something you are born with. You develop the condition later.
ICD-10-CM Diagnosis Code D59 D59.
Other megaloblastic anemias, not elsewhere classified D53. 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D53. 1 became effective on October 1, 2021.